XERS
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Xeris Biopharma Holdings, Inc. total liabilities for the quarter ending December 31, 2025 were 369.8M, a 4.87% increase year-over-year.
- Xeris Biopharma Holdings, Inc. total liabilities for 2025 were 369.8M, a 4.87% increase from 2024.
- Xeris Biopharma Holdings, Inc. total liabilities for 2024 were 352.7M, a 7.07% increase from 2023.
- Xeris Biopharma Holdings, Inc. total liabilities for 2023 were 329.4M, a 10.04% increase from 2022.
- Xeris Biopharma Holdings, Inc. total liabilities for 2022 were 299.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Xeris Biopharma Holdings, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $370 |
| 2024 | $353 |
| 2023 | $329 |
| 2022 | $299 |
| 2021 | $209 |
| 2020 | $125 |
| Xeris Biopharma Holdings, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $370 |
| 2024-12-31 | $353 |
| 2023-12-31 | $329 |
| 2022-12-31 | $299 |
| 2021-12-31 | $209 |
| 2020-12-31 | $125 |
Xeris Biopharma Holdings, Inc. Total Liabilities — FAQ
Xeris Biopharma Holdings, Inc. (XERS) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's total liabilities history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s total liabilities by year and by quarter, including the growth rate.